date/time interval
- September 21, 2023 - August 31, 2028
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R01 CA286507-01
Affiliation
contributor
- Merghoub, Taha Principal Investigator (Subaward) 2023 - 2028